Pharma and Life Sciences Investigations and Prosecutions: The First Two Years of the Biden Administration -
With the two-year mark of the Biden presidency looming, the administration’s approach to prosecuting and...more
1/12/2023
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Corporate Governance ,
Criminal Prosecution ,
Digital Health ,
Enforcement ,
False Claims Act (FCA) ,
Life Sciences ,
Medicare Advantage ,
OPDP ,
Pharmaceutical Industry ,
Privacy Laws ,
Stocks ,
Telehealth
On March 21, 2022, the U.S. Securities and Exchange Commission (the “SEC”) published the proposed rule entitled the “Enhancement and Standardization of Climate-Related Disclosures” that would require registered public...more
In High River Limited Partnership v. Occidental Petroleum Corp., C.A. No. 2019-0403-JRS, 2019 WL 6040285 (Del. Ch. Nov. 14, 2019) (Slights, V.C.), the Delaware Court of Chancery held that a stockholder’s mere disagreement...more
Public reporting companies that have material weaknesses in their internal control over financial reporting (“ICFR”) are required under Rule 308 of the Securities Exchange Act of 1934, as amended, to report such material...more
2/6/2019
/ Audit Reports ,
Audits ,
Corporate Governance ,
Disclosure Requirements ,
Enforcement Actions ,
Financial Statements ,
ICFR ,
Internal Audit Functions ,
Material Misstatements ,
Proxy Statements ,
Securities and Exchange Commission (SEC)